adg126,tpst-1120,bevacizumab,tocilizumab,atezolizumab,ro7247669,tiragolumab
adagene,tempest,jw pharma,arcus biosciences,roche
['morpheus-liver', '$rcus', '$rhhby']
richard finn notes some baseline imbalances in morpheus-liver $rhhby tigit #asco23 $rcus 
Once had a blue tick. Journalist at Evaluate Vantage. Interested in: oncology, immunology. Not interested in: what stock you bought today.